While the representatives acknowledge that the agencies have made headway in the broader ADHD medicine shortage through efforts such as approving generics to Takeda’s Vyvanse and raising the ...
An ongoing shortage of medications prescribed to treat attention-deficit/hyperactivity disorder or ADHD, such as Adderall, has left many patients struggling to get ...
The national ADHD medicine shortage, which has impacted access to generic versions of Adderall, Vyvanse, and Concerta, was first announced back in October 2022. Now, 16 months later, patients are ...
Attention deficit hyperactivity disorder, or ADHD, is a common neurodevelopmental disorder that can affect children and adults. It’s often diagnosed during childhood or adolescence — in fact, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results